StockClub

MEDXF

MEDXFMedexus Pharmaceuticals Inc.$ --
Medexus Pharmaceuticals Inc.

Medexus Pharmaceuticals Inc.

MEDXF

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 12/31/2025FY2026 Q3
Revenue
25M USD
YoY -15.6%
Operating Income
2M USD
YoY -55.7%
Net Income
0M USD
YoY -89.1%
EPS
0$
YoY -88.6%

Revenue

$74.7M
FY2024 Q4$113.1M
$113.1M
Q4
FY2025 Q1$27.3M
$27.3M
Q1
FY2025 Q2$53.6M
$53.6M
Q2
FY2025 Q3$83.6M
$83.6M
Q3
FY2025 Q4$108.3M
$108.3M
Q4
FY2026 Q1$24.6M
$24.6M
Q1
FY2026 Q2$49.4M
$49.4M
Q2
FY2026 Q3$74.7M
$74.7M
Q3
Actual
$-8.9M (-10.6%)

Net Income

$281,000
FY2024 Q4$-214,000
$-214,000
Q4
FY2025 Q1$2M
$2M
Q1
FY2025 Q2$2.1M
$2.1M
Q2
FY2025 Q3$2.8M
$2.8M
Q3
FY2025 Q4$2.2M
$2.2M
Q4
FY2026 Q1$516,000
$516,000
Q1
FY2026 Q2$201,000
$201,000
Q2
FY2026 Q3$281,000
$281,000
Q3
Actual
$-2.5M (-90.0%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020BEAT
Actual:CAD52.4M
Est:CAD35.9M
FY2020BEAT
CAD52.4M
FY2021BEAT
Actual:CAD79.7M
Est:CAD68.8M
FY2021BEAT
CAD79.7M
FY2022BEAT
Actual:CAD76.7M
Est:CAD60M
FY2022BEAT
CAD76.7M
FY2023BEAT
Actual:CAD108.1M
Est:CAD79.6M
FY2023BEAT
CAD108.1M
FY2024MISS
Actual:CAD113.1M
Est:CAD113.9M
FY2024MISS
CAD113.1M
FY2025MISS
Actual:CAD108.3M
Est:CAD108.7M
FY2025MISS
CAD108.3M

Analyst Estimates